The latter in turn is responsible for an increased melanin count in the body
If youre intrigued by any of the treatments discussed here or if youre frustrated with conventional approaches and looking for a fresh start we invite you to explore LIVVs peptide therapies and weight loss programs
More recently, two dual-acting GLP-1/GIP agonists have been approved, Mounjaro (tirzepatide) for type 2 diabetes and Zepbound (tirzepatide) for chronic weight management
These findings have also been described for MDD, e.g., in a large meta-analysis by Bot and Milaneschi et al., which found an association between depression risk and different lipid classes [14] and in several other studies, as reviewed in detail by Guerreiro Costa et al
Skipping titration increases the likelihood of severe nausea, vomiting, prolonged diarrhea , and potentially dangerous dehydration
Diarrhoea was among the most frequently reported adverse effects in the Phase 2 NEJM trial, occurring in a dose-dependent pattern and most commonly during dose escalation